Mr. R., 64, arrives with an anterior STEMI and is already in shock: systolic pressure in the 80s on norepinephrine, lactate rising, ejection fraction about 25% on echo. He is awake and following commands. He is on the cath-lab table and the culprit artery has not yet been opened. The team is choosing between a balloon pump and a microaxial pump. The shock course follows him from the cath lab to the ICU; each trial answers one decision in his care.
This page helps you decide: A small trial showed a pump raised cardiac output more than a balloon pump. Does a better number mean a better outcome for Mr. R.?
After this page you can
Work through the six steps in order. Each question at the end belongs to one step, and the answer is on that step's page.
For Mr. R., ISAR-SHOCK answers only the physiology: a microaxial pump raised cardiac index more than a balloon pump at 30 minutes (+0.49 vs +0.11 L/min/m²), but 30-day death was 46% in both arms of a 26-patient trial, so a better number does not mean a better outcome. If he gets a pump, the reason is DanGer Shock and its selected-patient criteria. On the one-pager it sits on page 2, in the “Temporary mechanical support in AMI shock — what the randomized trials show” table, microaxial flow pump row.